Ace222.doc

MATERIAL SAFETY DATA SHEET
AMPICILLIN, SODIUM SALT
I IDENTIFICATION:
V FIRE AND EXPLOSION HAZARDS:
BioShop Canada Inc.
Flammable: No
4060 Fairview St Unit #6-8
Flash Point: N/A
Burlington, OntarioL7L 4Y8
Extinguishing Media: Water, dry chemical, chemical foam or alcohol
1-800-234-1179
resistant foam.
Explosion Data: Not available
Emergency Telephone No.: 905-466-3832
VI REACTIVITY:
Chemical Name: Ampicillin sodium salt
Catalog Number: AMP201
Stability: Stable under normal temperatures and pressure
Molecular Formula: C16H18N3O4SNa
Conditions to avoid; dust generation
Molecular Weight: 371.19
Incompatibility: strong oxidizing reagents
WHMIS Classification: D2A, D2B
Hazardous Decomposition Products: carbon monoxide, carbon dioxide,
TSCA Status: not listed on the TSCA Inventory
nitrogen oxides, oxides of sulfur
Hazardous Polymerization: Will not occur
II HAZARDOUS INGREDIENTS:
VII PHYSICAL DATA:
CAS # RTECS # %
Physical State: Solid
Ampicillin sodium
Appearance and Odor: white to off-white, odorless
Melting Point: 419° F
Boiling Point: n/a
Specific Gravity: n/a
III HAZARDS/TOXICOLOGICAL PROPERTIES:
Vapor Density:
Solubility: Soluble in water
Potential Health Effects: May be harmful if swallowed. May cause eye
and skin irritation. May cause allergic reactions
VIII PREVENTIVE MEASURES:
Target Organs: Eyes, skin respiratory system
Eyes: Causes eye irritation.
Skin: Causes skin irritation.
Personal Protection: Wear appropriate protective gloves and clothes to
Inhalation: May be harmful if swallowed. May cause irritation. May cause
nausea, vomiting. May cause allergic reaction causing anaphylactic shock Ventilation: Local exhaust systems.
Ingestion: Causes irritation. May cause allergic reaction.
Respiratory protection: Use NIOSH/MSHA approved full face-piece
CHRONIC HEALTH HAZARDS: No information.
respirator.
Leak and Spill Procedures: Wear appropriate protective equipment.
Exposure Limits:
Sweep up then place into a suitable container for disposal.
Waste Disposal: Follow local disposal regulations.
Storage Conditions: Store in a cool, dry place. Store in a tightly closed
container.
Label Hazard Warning: Irritating to eyes, respiratory system and skin.
Shipping Information: Not regulated
IX PREPARATION OF MSDS:
Epidemiology: No data available
Teratogenicity; No data available
Reproductive Effects: No data available
Neurotoxicity: No data available
Mutagenicity: No data available
Carcinogenicity: Not listed by ACGIH, IARC, NTP, or OSHA
The information provided on this Material Safety Data Sheet is furnished in good faith and without warranty of any kind. The above information is IV FIRST AID MEASURES:
believed to be correct and should be used only as a guide. BioShop CanadaInc. shall not be held liable for any damage resulting from the handling or Eyes: Flush eyes with plenty of water for at least 15 minutes.
from the contact with the above product.
Skin: Flush area immediately with plenty of soap and water while removing
contaminated clothing and shoes.
Observe all federal, provincial and state laws concerning health, Inhalation: Remove victim to fresh air. If not breathing give
artificial respiration. If breathing is difficult give oxygen and GET MEDICAL
ATTENTION.
Ingestion: Wash mouth with water. DO NOT INDUCE VOMITING.GET
MEDICAL ATTENTION.

Source: http://www.labempire.com/files/attachment/synced_AMP201.pdf

ddcpontiac.com

Digestive Disease Consultants Purchase these items ahead of time: 1. Four Dulcolax tablets (stool softeners or laxative) 2. One bottle of Miralax (230/238) Gram 3. Two 32-ounce bottles of Gatorade (no red colors), preferably clear 4. Tuck’s pads, Vaseline, Desitin etc can be used to protect the anal area if needed Colonoscopy Preparation Timeline Five or mor

Microsoft word - novastan 100 mgml conc for sol for inf eng

SUMMARY OF THE PRODUCT CHARACTERISTICS NAME OF THE MEDICINAL PRODUCT Novastan 100 mg/ml concentrate for solution for infusion. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml concentrate for solution for infusion contains 100 mg argatroban. 1 Vial with 2.5 ml concentrate for solution for infusion contains 250 mg argatroban. Final concentration after dilution as recommended is 1 mg/ml

Copyright © 2018 Predicting Disease Pdf